Fortitude Advisory Group L.L.C. Biocept Inc Transaction History

Fortitude Advisory Group L.L.C.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 25, 2022	SELL	$1.83 - $3.97 $58,560 - $127,040	-32,000 Closed	0 $0
Q4 2021 May 20, 2022	BUY	$3.43 - $4.22 $109,760 - $135,040	32,000 New	32,000 $116,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Fortitude Advisory Group L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fortitude Advisory Group L.L.C. with notifications on news.